Literature DB >> 15516486

Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect.

Christopher S Stevenson1, Kevin Coote, Ruth Webster, Helinor Johnston, Hazel C Atherton, Andrew Nicholls, June Giddings, Rosemary Sugar, Alan Jackson, Neil J Press, Zarin Brown, Keith Butler, Henry Danahay.   

Abstract

Repetitive, acute inflammatory insults elicited by cigarette smoke (CS) contribute to the development of chronic obstructive pulmonary disease (COPD), a disorder associated with lung inflammation and mucus hypersecretion. Presently, there is a poor understanding of the acute inflammatory mechanisms involved in this process. The aims of this study were to develop an acute model to investigate temporal inflammatory changes occurring after CS exposure. Rats were exposed to whole body CS (once daily) generated from filtered research cigarettes. Initial studies indicated the generation of a neutrophilic/mucus hypersecreting lung phenotype in <4 days. Subsequent studies demonstrated that just two exposures to CS (15 h apart) elicited a robust inflammatory/mucus hypersecretory phenotype that was used to investigate mechanisms driving this response. Cytokine-induced neutrophil chemoattractants (CINCs) 1-3, the rat growth-related oncogene-alpha family homologs, and IL-1beta demonstrated time-dependent increases in lung tissue or lavage fluid over the 24-h period following CS exposure. The temporal changes in the neutrophil chemokines, CINCs 1-3, mirrored increases in neutrophil infiltration, indicative of a role in neutrophil migration. In addition, a specific CXCR2 antagonist, SB-332235, effectively inhibited CS-induced neutrophilia in a dose-dependent manner, supporting this conclusion. This modeling of the response of the rat airways to acute CS exposure indicates 1) as few as two exposures to CS will induce a phenotype with similarities to COPD and 2) a novel role for CINCs in the generation of this response. These observations represent a paradigm for the study of acute, repetitive lung insults that contribute to the development of chronic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516486     DOI: 10.1152/ajplung.00317.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  31 in total

1.  Long-Term Sequelae of Smoking and Cessation in Spontaneously Hypertensive Rats.

Authors:  Ching-Wen Wu; Tammy Yau; Ciara C Fulgar; Savannah M Mack; Alina M Revilla; Nicholas J Kenyon; Kent E Pinkerton
Journal:  Toxicol Pathol       Date:  2019-12-24       Impact factor: 1.902

2.  Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice.

Authors:  Sharon A McGrath-Morrow; Thomas Lauer; J Michael Collaco; Min Yee; Michael O'Reilly; Wayne Mitzner; Enid Neptune; Robert Wise; Shyam Biswal
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-14       Impact factor: 6.914

3.  Exposure to neonatal cigarette smoke causes durable lung changes but does not potentiate cigarette smoke-induced chronic obstructive pulmonary disease in adult mice.

Authors:  Sharon McGrath-Morrow; Deepti Malhotra; Thomas Lauer; J Michael Collaco; Wayne Mitzner; Enid Neptune; Robert Wise; Shyam Biswal
Journal:  Exp Lung Res       Date:  2011-06-07       Impact factor: 2.459

Review 4.  Targeting pro-resolution pathways to combat chronic inflammation in COPD.

Authors:  Steven Bozinovski; Desiree Anthony; Ross Vlahos
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

Review 5.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

Authors:  Jeffrey L Curtis; Christine M Freeman; James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2007-10-01

Review 6.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

7.  Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation.

Authors:  Wing-Yan Heidi Wan; Abigail Morris; Gillian Kinnear; William Pearce; Joanie Mok; Daniel Wyss; Christopher S Stevenson
Journal:  Respir Res       Date:  2010-09-18

8.  Alteration of the immunological synapse in lung cancer: a microenvironmental approach.

Authors:  S Derniame; J-M Vignaud; G C Faure; M C Béné
Journal:  Clin Exp Immunol       Date:  2008-08-29       Impact factor: 4.330

9.  p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure.

Authors:  Nivedita Tiwari; Amarnath S Marudamuthu; Yoshikazu Tsukasaki; Mitsuo Ikebe; Jian Fu; Sreerama Shetty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

10.  Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.

Authors:  Teresa R Johnson; Marc E Rothenberg; Barney S Graham
Journal:  J Leukoc Biol       Date:  2008-06-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.